Imunon, Inc.
IMNN
$0.849
$0.01181.41%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -385.64% | 16.80% | |||
| Gross Profit | 385.64% | -16.80% | |||
| SG&A Expenses | 14.70% | -23.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.43% | -1.04% | |||
| Operating Income | 16.43% | 1.04% | |||
| Income Before Tax | 16.27% | -1.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 16.27% | -1.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.27% | -1.20% | |||
| EBIT | 16.43% | 1.04% | |||
| EBITDA | 16.10% | 0.97% | |||
| EPS Basic | 16.70% | 34.14% | |||
| Normalized Basic EPS | 16.70% | 34.15% | |||
| EPS Diluted | 16.70% | 34.14% | |||
| Normalized Diluted EPS | 16.70% | 34.15% | |||
| Average Basic Shares Outstanding | 0.54% | 53.66% | |||
| Average Diluted Shares Outstanding | 0.54% | 53.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||